Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.8900
+0.0300 (1.61%)
NASDAQ · Last Trade: May 1st, 1:15 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors